Literature DB >> 8806802

Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis.

E F Rosloniec1, K B Whittington, D D Brand, L K Myers, J M Stuart.   

Abstract

Collagen-induced arthritis (CIA), an autoimmune arthritis model, is elicited by the immunization of genetically susceptible strains of mice with type II collagen (CII). We have analyzed the molecular interactions that occur during the presentation of the immunodominant determinant within CII(257-270) by the murine class II susceptibility allele, I.Aq. Utilizing a soluble I-A binding assay and clonally distinct CII-specific T cells, we have identified the residues that control the ability of the CII(257-270) peptide to bind to I-Aq and those that interact with the TCR. In competitive binding assays with a panel of analog peptides, only two residues within CII(257-270) were found to participate in the binding of this peptide to I-Aq, residues 260 (Ile) and 263 (Phe). When these substitutions were combined into a single peptide, no binding of the peptide to I-Aq could be detected. Although no other substitutions decreased the binding affinity of the peptides, substitution of several amino acid residues lying outside of the determinant core increased the peptide's affinity for I-Aq and in some instances greatly enhanced the potency of the peptide in stimulating T cells. In antigen presentation assays, clonotypic variation in the recognition of several analog peptides indicated that residues 261, 262, 264, 266, and 267 are likely TCR contact sites. Since residue 266 interacts with the TCR and is the only residue in this determinant that differs between chick/bovine CII and mouse CII, these data indicate that immunity to the autoantigen may play a role in this model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806802     DOI: 10.1006/cimm.1996.0210

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  17 in total

1.  Peptide ligand structure and I-Aq binding avidity influence T cell signaling pathway utilization.

Authors:  Linda K Myers; David L Cullins; Jeoung-Eun Park; Ae-Kyung Yi; David D Brand; Edward F Rosloniec; John M Stuart; Andrew H Kang
Journal:  Clin Immunol       Date:  2015-05-14       Impact factor: 3.969

2.  Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.

Authors:  Inger Gjertsson; Karen L Laurie; James Devitt; Steven J Howe; Adrian J Thrasher; Rikard Holmdahl; Kenth Gustafsson
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

3.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Authors:  Kristine A Kuhn; Liudmila Kulik; Beren Tomooka; Kristin J Braschler; William P Arend; William H Robinson; V Michael Holers
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

4.  Shaping of the autoreactive regulatory T cell repertoire by thymic cortical positive selection.

Authors:  Julie Ribot; Geneviève Enault; Sylvie Pilipenko; Anne Huchenq; Maryline Calise; Denis Hudrisier; Paola Romagnoli; Joost P M van Meerwijk
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

5.  MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.

Authors:  Jianya Huan; Laurie J Kaler; Jeffery L Mooney; Sandhya Subramanian; Corwyn Hopke; Arthur A Vandenbark; Edward F Rosloniec; Gregory G Burrows; Halina Offner
Journal:  J Immunol       Date:  2008-01-15       Impact factor: 5.422

6.  Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis.

Authors:  M De Santis; A Ceribelli; F Cavaciocchi; E Generali; M Massarotti; N Isailovic; C Crotti; H U Scherer; C Montecucco; C Selmi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

7.  Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis.

Authors:  Anna-Karin E Palm; Heike C Friedrich; Anja Mezger; Maya Salomonsson; Linda K Myers; Sandra Kleinau
Journal:  Cell Mol Immunol       Date:  2015-05-11       Impact factor: 11.530

8.  Design of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritis.

Authors:  Ida E Andersson; C David Andersson; Tsvetelina Batsalova; Balik Dzhambazov; Rikard Holmdahl; Jan Kihlberg; Anna Linusson
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

9.  Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.

Authors:  Keiichi Iwanami; Isao Matsumoto; Yohei Yoshiga; Asuka Inoue; Yuya Kondo; Kayo Yamamoto; Yoko Tanaka; Reiko Minami; Taichi Hayashi; Daisuke Goto; Satoshi Ito; Yasuharu Nishimura; Takayuki Sumida
Journal:  Arthritis Res Ther       Date:  2009-11-09       Impact factor: 5.156

10.  Insights into spatial configuration of a galactosylated epitope required to trigger arthritogenic T-cell receptors specific for the sugar moiety.

Authors:  Simon Glatigny; Marie-Agnès Blaton; Julien Marin; Sylvie Mistou; Jean-Paul Briand; Gilles Guichard; Catherine Fournier; Gilles Chiocchia
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.